Inovio Pharmaceuticals's total assets for Q4 2025 were $74.31M, an increase of 7.10% from the previous quarter. INO total liabilities were $50.21M for the fiscal quarter, a -34.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.